SUCCESSFUL GENERATION OF TUMOR-INFILTRATING LYMPHOCYTE (TIL) PRODUCT FROM RENAL CELL CARCINOMA (RCC) TUMORS FOR ADOPTIVE CELL THERAPY

被引:1
|
作者
Halbert, Brian
Einstein, David
McDermott, David
Andrianopoulos, Emanuelle
Gupta, Mamta
Seery, Virginia
Onimus, Kenneth
Herman, Courtney
Wells, Adrian
Lakshmipathi, Shwetha
Natarajan, Arvind
Veerapathran, Anand
Bhatt, Rupal
Halbert, Brian
机构
关键词
D O I
10.1136/jitc-2021-SITC2021.176
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
176
引用
收藏
页码:A188 / A188
页数:1
相关论文
共 50 条
  • [21] CHARACTERIZATION OF FRESH (UNCULTURED) TUMOR-INFILTRATING LYMPHOCYTES (TIL) AND TIL-DERIVED T-CELL LINES FROM PATIENTS WITH RENAL-CELL CARCINOMA
    MITROPOULOS, D
    KOOI, S
    RODRIQUEZVILLANUEVA, J
    PLATSOUCAS, CD
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A97 - A97
  • [22] CHARACTERIZATION OF FRESH (UNCULTURED) TUMOR-INFILTRATING LYMPHOCYTES (TIL) AND TIL-DERIVED T-CELL LINES FROM PATIENTS WITH RENAL-CELL CARCINOMA
    MITROPOULOS, D
    KOOI, S
    RODRIGUEZVILLANUEVA, J
    PLATSOUCAS, CD
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 97 (02): : 321 - 327
  • [23] Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
    Saint-Jean, Melanie
    Knol, Anne-Chantal
    Volteau, Christelle
    Quereux, Gaelle
    Peuvrel, Lucie
    Brocard, Anabelle
    Pandolfino, Marie-Christine
    Saiagh, Soraya
    Nguyen, Jean-Michel
    Bedane, Christophe
    Basset-Seguin, Nicole
    Khammari, Amir
    Dreno, Brigitte
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [24] Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
    Yunger, Sharon
    Barel, Assaf
    Zeltzer, Li-at
    Fridman, Eddie
    Raviv, Gil
    Laufer, Menachem
    Schachter, Jacob
    Markel, Gal
    Itzhaki, Orit
    Besser, Michal J.
    ONCOIMMUNOLOGY, 2019, 8 (12):
  • [25] STUDY OF TUMOR-INFILTRATING LYMPHOCYTES FOR ADOPTIVE THERAPY OF RENAL-CELL CARCINOMA (RCC) AND METASTATIC MELANOMA - SEQUENTIAL PROLIFERATION OF CYTOTOXIC NATURAL-KILLER AND NONCYTOTOXIC T-CELLS IN RCC
    HAYAKAWA, K
    SALMERON, MA
    PARKINSON, DR
    MARKOWITZ, AB
    VONESCHENBACH, AC
    LEGHA, SS
    BALCH, CM
    ROSS, MI
    AUGUSTUS, LB
    ITOH, K
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (05) : 313 - 325
  • [26] White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy
    Weber, Jeffrey
    Atkins, Michael
    Hwu, Patrick
    Radvanyi, Laszlo
    Sznol, Mario
    Yee, Cassian
    CLINICAL CANCER RESEARCH, 2011, 17 (07) : 1664 - 1673
  • [27] Rejuvenation of tumor-infiltrating lymphocytes (TIL): A novel strategy to revitalize TIL antitumor function for cell therapy
    Vizcardo, Raul
    Huang, Yin
    Fioravanti, Jessica
    Maeda, Takuya
    Tamaoki, Naritaka
    Yamazaki, Yasuhiro
    Kutlu, Burak
    Bahl, Kriti
    Wang, Biao
    Zhong, Zheng
    Potluri, Shobha
    Restifo, Nicholas P.
    Lee, Gary
    CANCER RESEARCH, 2024, 84 (06)
  • [28] Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma
    Kazama, Akira
    Bilim, Vladimir
    Tasaki, Masayuki
    Anraku, Tsutomu
    Kuroki, Hiroo
    Shirono, Yuko
    Murata, Masaki
    Hiruma, Kaede
    Tomita, Yoshihiko
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma
    Akira Kazama
    Vladimir Bilim
    Masayuki Tasaki
    Tsutomu Anraku
    Hiroo Kuroki
    Yuko Shirono
    Masaki Murata
    Kaede Hiruma
    Yoshihiko Tomita
    Scientific Reports, 12
  • [30] TUMOR-INFILTRATING LYMPHOCYTES IN PATIENTS WITH RENAL-CELL CARCINOMA
    FINKE, JH
    TUBBS, R
    CONNELLY, B
    PONTES, E
    MONTIE, J
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 532 : 387 - 394